SIDS and Genetics: The HADHA Gene Research
The short answer
Research has identified links between certain genetic variants and increased SIDS risk, including variants in the HADHA gene (involved in fatty acid oxidation) and genes related to cardiac ion channels, serotonin signaling, and immune function. Fatty acid oxidation disorders, detectable through newborn screening, account for a small percentage of previously unexplained infant deaths. However, SIDS is likely multifactorial, involving a vulnerable infant, a critical developmental period, and an external stressor. Genetic factors may increase vulnerability but are rarely the sole cause.
This is one of the most common questions parents ask. Searching for answers means you care.
By Age
What to expect by age
0-6 months
The triple risk model for SIDS proposes that deaths occur when three factors converge: an underlying vulnerability (which may include genetic predisposition), a critical developmental period (peak SIDS risk is 2-4 months), and an external stressor (unsafe sleep environment, overheating, respiratory infection). Research on the HADHA gene and other fatty acid oxidation genes has shown that defects in mitochondrial fatty acid metabolism can impair the body's ability to respond to metabolic stress during sleep. Newborn metabolic screening (done at birth in all US states) can detect many of these disorders.
Genetic research context
Multiple genetic pathways have been implicated in SIDS vulnerability. Cardiac channelopathies (variants in SCN5A, KCNQ1, KCNH2 genes) may cause fatal heart rhythm abnormalities during sleep. Serotonin system variants may impair the brainstem's ability to arouse a baby from sleep when oxygen levels drop. Immune response genes may increase vulnerability to infections that trigger SIDS. However, carrying a genetic variant associated with SIDS risk does not mean a baby will die. Environmental factors and safe sleep practices remain the most modifiable risk factors.
Family implications
If a family has experienced a SIDS loss, the recurrence risk for subsequent siblings is slightly elevated but still very low (approximately 5-6 times the general population risk, which translates to roughly 1 in 1,000 to 1 in 2,000). Genetic counseling may be offered, and some families pursue molecular autopsy or genetic testing. For subsequent babies, providers may recommend home apnea monitoring (though its ability to prevent SIDS is unproven), strict safe sleep practices, and closer medical follow-up. Support organizations like First Candle can provide both emotional support and practical guidance.
What Should You Do?
When to take action
- Wanting to understand the latest SIDS research and genetic findings
- Your newborn's metabolic screening (heel prick test) was normal
- Having general anxiety about SIDS as a new parent
- You have a family history of SIDS or unexplained infant death
- Your baby's newborn screening flagged a metabolic disorder
- You want to discuss whether genetic testing is appropriate for your family
- You have significant anxiety about SIDS that is affecting your daily functioning
- You find your baby unresponsive, not breathing, or blue - call 911 and begin infant CPR
- Your baby has a sudden episode of going limp, turning blue, or stopping breathing
- Your newborn screening results indicate a fatty acid oxidation disorder - follow up with your pediatrician immediately
Sources
Related Resources
Trust your instincts. If something feels wrong, reach out to your pediatrician.
Worrying about your baby means you care. That is a good thing.
Related Medical Concerns
SIDS Blood Biomarker Research: What We Know
In 2022, Australian researchers published a study identifying lower levels of butyrylcholinesterase (BChE) in dried blood spots of babies who later died of SIDS compared to controls. While this research generated enormous interest and hope, it is still in very early stages and no validated screening test currently exists. The findings need replication in larger studies before any clinical test could be developed. The best current protection remains following AAP safe sleep guidelines: back to sleep, firm flat surface, room-sharing without bed-sharing.
Sudden Unexpected Infant Death (SUID): Prevention Strategies
Sudden Unexpected Infant Death (SUID) includes SIDS, accidental suffocation in a sleep environment, and other unexplained deaths. About 3,400 infants die from SUID annually in the US. Following AAP safe sleep guidelines can significantly reduce the risk: always place babies on their backs to sleep on a firm, flat surface; share a room but not a bed; remove all soft bedding, pillows, and toys from the sleep space; avoid overheating; offer a pacifier at sleep time; and maintain a smoke-free environment.
Safe Sleep Misinformation on Social Media
Social media is filled with baby sleep advice that contradicts evidence-based safe sleep guidelines from the AAP. Popular viral "hacks" including nest-like sleepers, inclined positioners, weighted sleep sacks for young infants, and bed-sharing arrangements may look cozy in photos but are associated with increased risk of SIDS and sleep-related infant deaths. The AAP safe sleep guidelines are clear: babies should sleep alone, on their backs, on a firm flat surface, with no soft bedding, bumpers, or positioning devices.
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.